BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32111456)

  • 21. Monitoring breast cancer response to neoadjuvant chemotherapy with ultrasound signal statistics and integrated backscatter.
    Piotrzkowska-Wróblewska H; Dobruch-Sobczak K; Klimonda Z; Karwat P; Roszkowska-Purska K; Gumowska M; Litniewski J
    PLoS One; 2019; 14(3):e0213749. PubMed ID: 30870478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast Cancer Treatment Response Monitoring Using Quantitative Ultrasound and Texture Analysis: Comparative Analysis of Analytical Models.
    Sannachi L; Gangeh M; Tadayyon H; Gandhi S; Wright FC; Slodkowska E; Curpen B; Sadeghi-Naini A; Tran W; Czarnota GJ
    Transl Oncol; 2019 Oct; 12(10):1271-1281. PubMed ID: 31325763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients.
    Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH
    Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Teruel JR; Heldahl MG; Goa PE; Pickles M; Lundgren S; Bathen TF; Gibbs P
    NMR Biomed; 2014 Aug; 27(8):887-96. PubMed ID: 24840393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast-lesions characterization using Quantitative Ultrasound features of peritumoral tissue.
    Klimonda Z; Karwat P; Dobruch-Sobczak K; Piotrzkowska-Wróblewska H; Litniewski J
    Sci Rep; 2019 May; 9(1):7963. PubMed ID: 31138822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
    Wu J; Gong G; Cui Y; Li R
    J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype.
    Candelaria RP; Bassett RL; Symmans WF; Ramineni M; Moulder SL; Kuerer HM; Thompson AM; Yang WT
    Oncologist; 2017 Apr; 22(4):394-401. PubMed ID: 28314842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of evaluating tumor vascularization using 3D power Doppler ultrasound with high-definition flow technology in the prediction of the response to neoadjuvant chemotherapy for T2 breast cancer: a preliminary report.
    Shia WC; Chen DR; Huang YL; Wu HK; Kuo SJ
    Phys Med Biol; 2015 Oct; 60(19):7763-78. PubMed ID: 26393306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Texture analysis based on contrast-enhanced MRI can predict treatment response to neoadjuvant chemotherapy of breast cancer].
    Sun SH; Zhou CW; Zhao LY; Zhang RZ; Ouyang H
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):344-349. PubMed ID: 28535650
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of ultrasound for monitoring breast tumour response to pro-adjuvant therapy.
    Gawne-Cain ML; Smith E; Darby M; Given-Wilson R
    Clin Radiol; 1995 Oct; 50(10):681-6. PubMed ID: 7586959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy.
    Wan CF; Liu XS; Wang L; Zhang J; Lu JS; Li FH
    Eur J Radiol; 2018 Jun; 103():118-123. PubMed ID: 29803376
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Tadayyon H; Gangeh M; Sannachi L; Trudeau M; Pritchard K; Ghandi S; Eisen A; Look-Hong N; Holloway C; Wright F; Rakovitch E; Vesprini D; Tran WT; Curpen B; Czarnota G
    Oncotarget; 2019 Jun; 10(39):3910-3923. PubMed ID: 31231468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated breast volume scanner (ABVS) compared to handheld ultrasound (HHUS) and contrast-enhanced magnetic resonance imaging (CE-MRI) in the early assessment of breast cancer during neoadjuvant chemotherapy: an emerging role to monitoring tumor response?
    D'Angelo A; Orlandi A; Bufi E; Mercogliano S; Belli P; Manfredi R
    Radiol Med; 2021 Apr; 126(4):517-526. PubMed ID: 33385300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound-Guided Diffuse Optical Tomography for Predicting and Monitoring Neoadjuvant Chemotherapy of Breast Cancers: Recent Progress.
    Xu C; Vavadi H; Merkulov A; Li H; Erfanzadeh M; Mostafa A; Gong Y; Salehi H; Tannenbaum S; Zhu Q
    Ultrason Imaging; 2016 Jan; 38(1):5-18. PubMed ID: 25887527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective trial of breast MRI versus 2D and 3D ultrasound for evaluation of response to neoadjuvant chemotherapy.
    Lee MC; Gonzalez SJ; Lin H; Zhao X; Kiluk JV; Laronga C; Mooney B
    Ann Surg Oncol; 2015 Sep; 22(9):2888-94. PubMed ID: 25589151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging Biomarkers for Precision Medicine in Locally Advanced Breast Cancer.
    Tran WT; Childs C; Probst H; Farhat G; Czarnota GJ
    J Med Imaging Radiat Sci; 2018 Dec; 49(4):342-351. PubMed ID: 30514549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
    Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
    J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
    Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy-Response Monitoring of Breast Cancer Patients Using Quantitative Ultrasound-Based Intra-Tumour Heterogeneities.
    Sadeghi-Naini A; Sannachi L; Tadayyon H; Tran WT; Slodkowska E; Trudeau M; Gandhi S; Pritchard K; Kolios MC; Czarnota GJ
    Sci Rep; 2017 Sep; 7(1):10352. PubMed ID: 28871171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative Ultrasound for Evaluation of Tumour Response to Ultrasound-Microbubbles and Hyperthermia.
    Sharma D; Carter H; Sannachi L; Cui W; Giles A; Saifuddin M; Czarnota GJ
    Technol Cancer Res Treat; 2023; 22():15330338231200993. PubMed ID: 37750232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.